Tweet
Nippon Rinsho. 2010 Sep;68(9):1679-84.
[Current anti-influenza virus chemotherapy]
[Article in Japanese]
Yoshioka D, Tokimatsu I, Ishii H, Kadota J.
Internal Medicine II, Oita University, Faculty of Medicine.
Abstract
The environment surrounding influenza is changing in recent years. In the spring of 2009, pandemic (H1N1) 2009 occurred in Mexico, and became epidemic on a global scale thereafter. Therefore, control of influenza is very important all over the world. Now in Japan, four specific anti-influenza antiviral drugs are available: amantadine, oseltamivir, zanamivir and peramivir. Pandemic (H1N1) 2009 are amantadine-resistant viruses, thus is not recommended for use. Oseltamivir is most commonly used in Japan, however, we have to pay attention to oseltamivir-resistant influenza virus. Almost no zanamivir-resistant influenza virus has been so far reported. In Japan, peramivir is the first drip infusion medicine and is expected to be used in severe cases.
PMID: 20845747 [PubMed - in process]
[Current anti-influenza virus chemotherapy]
[Article in Japanese]
Yoshioka D, Tokimatsu I, Ishii H, Kadota J.
Internal Medicine II, Oita University, Faculty of Medicine.
Abstract
The environment surrounding influenza is changing in recent years. In the spring of 2009, pandemic (H1N1) 2009 occurred in Mexico, and became epidemic on a global scale thereafter. Therefore, control of influenza is very important all over the world. Now in Japan, four specific anti-influenza antiviral drugs are available: amantadine, oseltamivir, zanamivir and peramivir. Pandemic (H1N1) 2009 are amantadine-resistant viruses, thus is not recommended for use. Oseltamivir is most commonly used in Japan, however, we have to pay attention to oseltamivir-resistant influenza virus. Almost no zanamivir-resistant influenza virus has been so far reported. In Japan, peramivir is the first drip infusion medicine and is expected to be used in severe cases.
PMID: 20845747 [PubMed - in process]
